Fibronectin-mononuclear cell interactions regulate type 1 helper T cell cytokine network in tolerant transplant recipients

被引:15
作者
Coito, AJ [1 ]
Onodera, K [1 ]
Kato, H [1 ]
Busuttil, RW [1 ]
Kupiec-Weglinski, JW [1 ]
机构
[1] Univ Calif Los Angeles, Sch Med, Dumont UCLA Transplant Ctr, Div Liver & Pancreas Transplantat, Los Angeles, CA 90095 USA
关键词
D O I
10.1016/S0002-9440(10)64636-6
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Fibronectin (FN), expressed primarily by macrophages, endothelial cells, and smooth muscle cells, represents an integral feature of the rejection response in transplant recipients, Here we demonstrate a unique pattern of cellular FN expression in rat recipients of cardiac allografts rendered tolerant in an infectious manner with either nondepleting CD4 mAb or regulatory spleen cells. Unlike in rejecting controls, cellular FN in tolerant hosts was restricted to the graft vessels and no vascular cell adhesion molecule-1 or intercellular adhesion molecule-1 expression could be found, supporting the role of FN in leukocyte sequestration at the graft site. The lack of myocardial FN in tolerant rats, despite dense macrophage infiltration, correlated with profound depression of Th1 (interleukin-2 and interferon-gamma) cytokines. Treatment with CD4-depleting mAb prevented tolerance induction and restored myocardial expression of FN in parallel with marked increase in the expression of interleukin-2 and interferon-gamma mRNA/protein. furthermore, connective segment-1 peptide-facilitated adjunctive blockade of FN-alpha 4 beta 1 interactions in recipients conditioned with CD4 depleting mAb, significantly depressed intragraft expression of interleukin-2 and interferon-gamma mRNA/protein. Hence, the lack of FN associated with infiltrating leukocytes plays an important role in the maintenance of tolerance in transplant recipients by depressing local expression of Th1 cytokines that otherwise facilitate acute graft rejection.
引用
收藏
页码:1207 / 1218
页数:12
相关论文
共 79 条
  • [51] ACTIVATION OF CD4 CELLS BY FIBRONECTIN AND ANTI-CD3 ANTIBODY - A SYNERGISTIC EFFECT MEDIATED BY THE VLA-5 FIBRONECTIN RECEPTOR COMPLEX
    MATSUYAMA, T
    YAMADA, A
    KAY, J
    YAMADA, KM
    AKIYAMA, SK
    SCHLOSSMAN, SF
    MORIMOTO, C
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1989, 170 (04) : 1133 - 1148
  • [52] LOCALIZATION AND CHEMICAL SYNTHESIS OF FIBRONECTIN PEPTIDES WITH MELANOMA ADHESION AND HEPARIN BINDING ACTIVITIES
    MCCARTHY, JB
    CHELBERG, MK
    MICKELSON, DJ
    FURCHT, LT
    [J]. BIOCHEMISTRY, 1988, 27 (04) : 1380 - 1388
  • [53] McCarthy JB, 1997, J IMMUNOL, V159, P2424
  • [54] BLOCKADE OF VERY LATE ANTIGEN-4 INTEGRIN BINDING TO FIBRONECTIN WITH CONNECTING SEGMENT-1 PEPTIDE REDUCES ACCELERATED CORONARY ARTERIOPATHY IN RABBIT CARDIAC ALLOGRAFTS
    MOLOSSI, S
    ELICES, M
    ARRHENIUS, T
    DIAZ, R
    COULBER, C
    RABINOVITCH, M
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1995, 95 (06) : 2601 - 2610
  • [55] Fibronectin type III5 repeat contains a novel cell adhesion sequence, KLDAPT, which binds activated alpha 4 beta 1 and alpha 4 beta 7 integrins
    Moyano, JV
    Carnemolla, B
    DominguezJimenez, C
    GarciaGila, M
    Albar, JP
    SanchezAparicio, P
    Leprini, A
    Querze, G
    Zardi, L
    GarciaPardo, A
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (40) : 24832 - 24836
  • [56] NICKELEIT V, 1995, AM J PATHOL, V147, P965
  • [57] LIGATION OF VLA-4 ON T-CELLS STIMULATES TYROSINE PHOSPHORYLATION OF A 105-KD PROTEIN
    NOJIMA, Y
    ROTHSTEIN, DM
    SUGITA, K
    SCHLOSSMAN, SF
    MORIMOTO, C
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1992, 175 (04) : 1045 - 1053
  • [58] Distinct tolerance pathways in sensitized allograft recipients after selective blockade of activation signal 1 or signal 2
    Onodera, K
    Chandraker, A
    Volk, HD
    Ritter, T
    Lehmann, M
    Kato, H
    Sayegh, MH
    Kupiec-Weglinski, JW
    [J]. TRANSPLANTATION, 1999, 68 (02) : 288 - 293
  • [59] Onodera K, 1997, J IMMUNOL, V158, P1572
  • [60] Onodera K, 1996, J IMMUNOL, V157, P1944